GenoLogics today announced that Wellcome Trust is deploying its lab and data management solution for genomics, including integrations to next generation sequencing platforms.

 

The Wellcome Trust Centre for Human Genetics (WTCHG) undertakes research into the genetic basis of multi-factorial diseases such as hypertension, diabetes, heart disease, infectious diseases, psychiatric disorders and multiple sclerosis. The Genomics Group of the Centre not only conducts research and development, but also provides a number of services for the Centre and other University of Oxford groups. Areas of interest include microarray, high-throughput quantitative gene expression, high-throughput genotyping and other specialties.

 

According to Dr. Ioannis Ragoussis, Head of Genomics at the Wellcome Trust Centre for Human Genetics, “we selected Geneus for our centralized lab and data management platform because of its flexibility to automate data capture from a wide range of genomics instruments and applications, while allowing us to more efficiently track samples and QC results across numerous projects.” Dr. Ragoussis went on to say, “a primary consideration in our selection of Geneus was the platform’s capability to fully integrate to our next generation sequencing instruments from Illumina and Roche, and automatically pipeline data for downstream analysis.”

 

Since Geneus is designed for the unique needs of genomics research facilities, the lab and data management solution can be deployed quickly to provide the Centre with immediate value. Pre-configured integrations across many instruments, including Illumina’s Genome Analyzer, means Geneus will improve the efficiency of the Centre as well as the quality of the data. This includes configuring the system for range of applications such as ChIP sequencing, resequencing, whole genome sequencing and genome wide association studies. By using GenoLogics’ web collaboration tool, LabLink, and adaptive reporting engine, the Centre will also be able to easily generate and share results with its customers.

 

“Geneus is one of the only solutions available in the marketplace today that is purpose built for genomics labs and provides seamless integrations to many instruments including next generation sequencing platforms”, said Michael Ball, CEO for GenoLogics. “For high throughput research facilities such as Wellcome Trust, Geneus provides a centralized yet flexible solution that is capable of managing large volumes of data from sample submissions to results.”

 

GenoLogics provides research organizations with informatics solutions for multiple sciences and technologies. Delivered as a set of modules on a common informatics platform, our solutions manage lab operations, while integrating research data across domains and providing superior sample traceability. Along with an automated bioinformatics pipelining system and reporting engine, our solutions transform data into results and enable advanced analysis.

 

 


About GenoLogics

GenoLogics is the leading provider of informatics solutions for translational research, spanning both the discovery and biomedical research domains. Our science purposed modules for discovery research are complemented by a highly configurable, integrating lab informatics platform that is scalable to service many labs and sciences across an organization. Our Biomedical Informatics product suite allows labs to track and manage their biospecimen and clinical annotations data, while aggregating results with our Research Informatics solution for a holistic view. For more information, please visit www.genologics.com.

 

 

###

 

 

GenoLogics Contact:                                                 

Bobbi Leach

Manager, Marketing Communications

250.483.7063

roberta.leach@genologics.com